Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and chiniofon

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with chiniofon in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(chiniofon)		Trials
(chiniofon)		Recent Studies (post-2010) (chiniofon)
9,1561875521,82351332

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, G; Fennessy, M1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and chiniofon

ArticleYear
Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.
    British journal of pharmacology, 1988, Volume: 94, Issue:4

    Topics: Animals; Female; Guinea Pigs; Histamine; Hydroxyquinolines; In Vitro Techniques; Lipoxygenase Inhibitors; Lung; Lung Compliance; Male; Platelet Activating Factor; Quinolines; SRS-A

1988